يحاولGOLD- Free

Tracking a new high

THE WEEK India|April 06, 2025
In the 1950s, Swiss company CIBA Pharmaceuticals developed a class of synthetic opioids known as Nitazenes.
- NIRMAL JOVIAL
Tracking a new high

Designed to target -μ-opioid receptors in the brain, they were intended as next-generation painkillers with greater efficacy than morphine. However, their extreme potency and high risk of respiratory depression led to their rejection for medical use.

For nearly six decades, Nitazenes remained confined to academic research as “tool drugs” for studying opioid receptor pharmacology. That changed in 2019 when illicit labs began producing analogues (a drug that shares structural or pharmacological similarities with an existing drug) based on historical pharmacological research. These powerful compounds quickly infiltrated drug markets, particularly in Europe and North America, with little public awareness compared to heroin or MDMA. Nitazenes soon became a significant addition to the evolving landscape of “new psychoactive substances” (NPS).

هذه القصة مأخوذة من طبعة April 06, 2025 من THE WEEK India.

ابدأ النسخة التجريبية المجانية من Magzter GOLD لمدة 7 أيام للوصول إلى آلاف القصص المتميزة المنسقة وأكثر من 9,000 مجلة وصحيفة.

Tracking a new high
Gold Icon

هذه القصة مأخوذة من طبعة April 06, 2025 من THE WEEK India.

ابدأ النسخة التجريبية المجانية من Magzter GOLD لمدة 7 أيام للوصول إلى آلاف القصص المتميزة المنسقة وأكثر من 9,000 مجلة وصحيفة.

المزيد من القصص من THE WEEK INDIA مشاهدة الكل
All eyes on Russia
THE WEEK India

All eyes on Russia

A popular legend in Slavic folklore is the myth of Baba Yaga.

time-read
2 mins  |
April 06, 2025
The man behind the myth
THE WEEK India

The man behind the myth

A new book brings alive the unknown side of LTTE leader Velupillai Prabhakaran

time-read
2 mins  |
April 06, 2025
Menopause is not an end, but another period
THE WEEK India

Menopause is not an end, but another period

Q/What is menopause?

time-read
2 mins  |
April 06, 2025
The opportunity in the crisis
THE WEEK India

The opportunity in the crisis

TARIFFS ARE IMPOSED by countries to protect domestic industry and, to a lesser extent, raise revenue.

time-read
3 mins  |
April 06, 2025
Understanding of menopause within medical community is variable
THE WEEK India

Understanding of menopause within medical community is variable

The Indian Menopause Society (IMS) is a multidisciplinary national society committed to fostering the comprehensive well-being of the mature and elderly Indian women. Excerpts from an interview with IMS president Dr Anita J. Shah, a gynaecologist in Surat since 1988.

time-read
3 mins  |
April 06, 2025
Count the sheep
THE WEEK India

Count the sheep

Sleep impacts physical and mental health, yet it remains a low priority

time-read
4 mins  |
April 06, 2025
India and Europe need to look at new alliances
THE WEEK India

India and Europe need to look at new alliances

THE WORLD IS CHANGING. It is highly unstable with geopolitical tensions that would last long term.

time-read
2 mins  |
April 06, 2025
Justice on trial
THE WEEK India

Justice on trial

Unless the Supreme Court takes full control of the process to remove corrupt judges of constitutional courts, the political class will step in

time-read
3 mins  |
April 06, 2025
The welfare worry
THE WEEK India

The welfare worry

The cost of populist schemes has Maharashtra reeling; Karnataka and Telangana, too, are struggling to foot the welfare bill

time-read
5 mins  |
April 06, 2025

نحن نستخدم ملفات تعريف الارتباط لتقديم خدماتنا وتحسينها. باستخدام موقعنا ، فإنك توافق على ملفات تعريف الارتباط. يتعلم أكثر